English
| dc.contributor.author | Cavusoglu, TG | |
| dc.contributor.author | Dariverenli, E | |
| dc.contributor.author | Vural, K | |
| dc.contributor.author | Ekerbicer, N | |
| dc.contributor.author | Ulman, C | |
| dc.contributor.author | Ölmez, E | |
| dc.contributor.author | Uysal, N | |
| dc.date.accessioned | 2024-07-18T11:57:44Z | |
| dc.date.available | 2024-07-18T11:57:44Z | |
| dc.description.abstract | WALTER DE GRUYTER GMBH | |
| dc.identifier.issn | 1303-829X | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/7148 | |
| dc.language.iso | Article | |
| dc.publisher | 0250-4685 | |
| dc.subject | Objectives: Type 2 diabetes is a common metabolic disease and anxiety disorders are very common among diabetics. Buspirone is used in the treatment of anxiety, also having blood glucose-lowering effects. The aim of the study was to investigate the effects of buspirone on the glucose and lipid metabolism as well as vascular function in type 2 diabetic rats. Methods: A type 2-diabetic model was induced through a high-fat diet for eight weeks followed by the administration of low-dose streptozotocin (35 mg/kg, intraperitoneal) in rats. Buspirone was given at two different doses (1.5 mg/kg/d and 5 mg/kg/d) and combined with metformin (300 mg/kg/d). The fasting glucose and insulin levels, lipid profile were analyzed, and vascular response measured from the thoracic aorta was also evaluated. Results: Both doses of buspirone caused a significant improvement in fasting blood glucose levels. In particular, the buspirone treatment, combined with metformin, improved endothelial dysfunction and was found to be correlated with decreased nitrate/nitrite levels. Conclusions: Buspirone may be effective in the treatment of type 2 diabetes, either alone or in combination with other treatments, particularly in terms of endothelial dysfunction, inflammation and impaired blood glucose, and insulin levels. | |
| dc.title | English | |
| dc.type | INSULIN-RESISTANCE | |
| dc.type | PLASMA-GLUCOSE | |
| dc.type | NITRIC-OXIDE | |
| dc.type | STREPTOZOTOCIN | |
| dc.type | CHOLESTEROL | |
| dc.type | MECHANISMS | |
| dc.type | SEROTONIN | |
| dc.type | STRESS | |
| dc.type | 5-HT |